In April 2023, researchers compared the performance of GPT-3.5, GPT-4 and human users on a practice ophthalmology written examination. The investigation focused on the American Academy of Ophthalmology (AAO) Basic and Clinical Science Course Self-Assessment Program Simulated Exam. GPT was fed all 260 multiple-choice questions from the exam and non-answers were marked as incorrect. According to the AAO, the questions were categorized by subject and the organization provided user performance information by question. Outcomes of the comparison were verified through established methodology.
GPT-4 and GPT-3.5 have demonstrated a passing score on United States Medical Licensing Examination Step exams [3]. Additionally, their performance on neurosurgery practice board tests matches that of neurosurgery residents [2]. Unfortunately, GPT-3 was unable to produce consistent and accurate answers for many questions from the mock ophthalmology exam [4]. Therefore, the research was conducted to analyse the performance of GPT-3.5, GPT-4 and human users on the practice ophthalmology written examination.
An important factor of this research is the company mentioned in the article itself, American Academy of Ophthalmology (AAO). It is one of the largest and authoritative organisations dedicated to the field of ophthalmology. AAO’s mission is to “empower ophthalmologists to provide the best possible care to their patients.” It accomplishes this through research studies, patient education, disease prevention services and advocacy initiatives, while also connecting professionals to support each other.
Moreover, researchers mention an established methodology [2] to validate their comparison outcomes. The methodology is designed by a person, Daniel Wooley. He is an expert in the field and renowned for his work on observational studies, preclinical models and a variety of clinical trials in the field of neuroscience. He is also a professor at Stanford University and published numerous works related to the field in leading journals and magazines. His research has contributed to the advancements in understanding diseases and developing treatments for neurological disorders.
